<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EAA6A1E7-D911-4B65-858C-A7BA596672CB"><gtr:id>EAA6A1E7-D911-4B65-858C-A7BA596672CB</gtr:id><gtr:name>Saint Mary's Hospital, Manchester</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A19A6372-A1A2-4F0D-AED7-7110E0A05C9B"><gtr:id>A19A6372-A1A2-4F0D-AED7-7110E0A05C9B</gtr:id><gtr:name>Sheffield Teaching Hospitals NHS Foundation Trust</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Reproduction and Endocrinology</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EAA6A1E7-D911-4B65-858C-A7BA596672CB"><gtr:id>EAA6A1E7-D911-4B65-858C-A7BA596672CB</gtr:id><gtr:name>Saint Mary's Hospital, Manchester</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A19A6372-A1A2-4F0D-AED7-7110E0A05C9B"><gtr:id>A19A6372-A1A2-4F0D-AED7-7110E0A05C9B</gtr:id><gtr:name>Sheffield Teaching Hospitals NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D68A5444-F384-4F91-A123-AF9D11ADA89D"><gtr:id>D68A5444-F384-4F91-A123-AF9D11ADA89D</gtr:id><gtr:firstName>DUSKO</gtr:firstName><gtr:surname>ILIC</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/745D2AD2-FA48-4B15-B420-C87DB4476433"><gtr:id>745D2AD2-FA48-4B15-B420-C87DB4476433</gtr:id><gtr:firstName>Alan</gtr:firstName><gtr:surname>Colman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801061"><gtr:id>0B4F7107-FA22-4D02-A7CF-67F22A1640DE</gtr:id><gtr:title>Derivation of clinical grade embryonic stem cell lines</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801061</gtr:grantReference><gtr:abstractText>Human embryonic stem (hES) cells can be isolated from early (6 day old) developing embryos which have been grown in the laboratory as part of, or surplus to some kinds of IVF treatment. Under certain conditions, these cells can be made to develop into different kinds of tissues, such as nerve cells or pancreatic cells which it is hoped in the future, may be useful in treating degenerative diseases such as Parkinson s disease and diabetes, or in spinal injuries by replacing the diseased or damaged cells with healthy hES cells which have been grown in the laboratory. The number of hES cell lines that have been developed worldwide that are suitable for clinical use is still very limited. Further research is required to find out the best means to grow them in ways that will allow them to be safe for clinical use which is the purpose of this grant. All stem cell derivation from embryos is strictly monitored in the UK and requires a licence from the Human Fertilisation and Embryology Authority (HFEA). In compliance with conditions of our HFEA licence, samples of any suitable stem cell lines developed will be sent to the UK Stem Cell Bank from where they are made available to research scientists in the UK and abroad through the MRC Stem Cell Steering Committee, and if suitable, for further preparation in the UKSCB for clinical use. With the Assisted Conception Unit (ACU) at Guy s, we have developed ethical ways of obtaining embryos for deriving stem cell lines that may be suitable for clinical use, especially from couples who have successfully undergone IVF treatment and have additional embryos in frozen storage which they no longer wish to use in their own treatment, nor wish to donate to other individuals. Rather than destroy them, patients often prefer to donate them for stem cell or other worthwhile research.</gtr:abstractText><gtr:technicalSummary>The development and support of the UK stem cell bank is a clear signal of the government?s commitment to support both local and international research in stem cell research, and to the development of lines suitable for clinical use. 
Although there have been important advances in the generation of hES, the derivation of lines for human use is tempered by the stringent requirements and methodological changes needed to meet GMP production standards. These include unequivocal permission from embryo donors for use of their embryos for therapeutic purposes without restrictions or financial claim, clear provenance of embryos including history, infectious agent of the donors, and documentation assuring traceability through the various stages from fertilization, though culture to blastocyst, and where indicated, cryopreservation. There also need to be changes to the methods for isolation of inner cell masses from blastocysts, moving away from the animal feeder layers for derivation and growth, and the use of more clearly defined media free of animal products. 
Key to successful hES generation is access to human embryos in vitro able to develop to the blastocyst stage and beyond, and suitable facilities to derive under conditions compliant with the EUTCD and the requirements of the HTA. Ethical access to good quality embryos has been facilitated through the large and successful assisted conception unit and PGD programme at Guy s Hospital where over 1000 cycles are performed annually. In addition, through our nurse coordinator funded by MRC, we have set up a strong collaboration with 9 local NHS and private IVF units to provide cryopreserved embryos surplus to patients therapeutic need and suitable for stem cell research. We have also secured an investment of #4m from the MRC, KCL, the Guys and St Thomas? Charity and the Trust, towards the build of a new assisted conception unit on the 11th floor of the Guy?s tower, to house IVF treatment facilities, PGD laboratories and a two-room GMP stem cell suite leading directly off the IVF laboratory, due for completion in July 2008. It is our intention to utilise these facilities to generate, grown and characterise under GMP conditions, embryonic stem cell lines suitable for deposit in the UK Stem Cell Bank as clinical grade lines. In response to this strategic call we are applying for staff, equipment and supplies to enable us fulfill this aim.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-03-19</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>801730</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sheffield Teaching Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Assisted Conception Unit</gtr:department><gtr:description>hESCCO (Human Embryonic Stem Cell Coordinators)</gtr:description><gtr:id>AFBC64EF-123E-4475-9282-3AE220DB7D82</gtr:id><gtr:impact>A group patient information and consent form has been produced in the past to give patients uniform information. The group has established a website in which to communicate. We have also produced a joint publication - Ref 18154466.</gtr:impact><gtr:outcomeId>E304A1F9490-2</gtr:outcomeId><gtr:partnerContribution>Knowledge transfer and experience.Knowledge transfer and experience</gtr:partnerContribution><gtr:piContribution>The hESCCO group was formed before this grant was approved. Therefore any collaborations made had already been established. With regard to this, we organised group meetings and established lines of communication between parties.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biochemical Engineering</gtr:department><gtr:description>Biochemical Engineering</gtr:description><gtr:id>FE76DA08-B145-4395-871B-AF9D8686614B</gtr:id><gtr:impact>Publications: 17465755 17635044 PhD student completed thesis http://eprints.ucl.ac.uk/18592/1/18592.pdf</gtr:impact><gtr:outcomeId>0BA0FD8030C-1</gtr:outcomeId><gtr:partnerContribution>Knowledge transfer and experience</gtr:partnerContribution><gtr:piContribution>Collaboration with Regenerative Medicine group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>EC FP6 Collaborative Projects</gtr:department><gtr:description>hESReg European Stem Cell Registry</gtr:description><gtr:id>1D24CF05-8C78-47DA-840C-BCCD9E59D6C8</gtr:id><gtr:impact>First European wide stem cell registry of Embryonic and iPS stem cells http://www.hescreg.eu/</gtr:impact><gtr:outcomeId>0189CA3D240-1</gtr:outcomeId><gtr:partnerContribution>Contribute to data in registry Braude is member of scientific advisory committee</gtr:partnerContribution><gtr:piContribution>Member of Scientific Advisory board and contributor to Bank registry</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Saint Mary's Hospital, Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>hESCCO (Human Embryonic Stem Cell Coordinators)</gtr:description><gtr:id>02942425-8D65-482A-8F9B-8581714AD59A</gtr:id><gtr:impact>A group patient information and consent form has been produced in the past to give patients uniform information. The group has established a website in which to communicate. We have also produced a joint publication - Ref 18154466.</gtr:impact><gtr:outcomeId>E304A1F9490-1</gtr:outcomeId><gtr:partnerContribution>Knowledge transfer and experience.Knowledge transfer and experience</gtr:partnerContribution><gtr:piContribution>The hESCCO group was formed before this grant was approved. Therefore any collaborations made had already been established. With regard to this, we organised group meetings and established lines of communication between parties.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Workshop on stem cell &amp; cancer research</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>506A80B7-CF8A-4C46-AF58-CE883C6F44AF</gtr:id><gtr:impact>CONFERENCE: King's College London and national Yang-Ming University, Taiwan, workshop on stem cell &amp;amp; cancer research
DATE: 17-19 Sep 2012
ORGANIZER: www.kcl.ac.uk
TITLE: Pluripotent stem cells at King's
AUTHORS: Dusko Ilic
LOCATION: King's College London, London, UK

networking, promotion of our research and resources</gtr:impact><gtr:outcomeId>sMXeoJNGEbC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar - London</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>6A9391D2-7D17-4BF2-8E8E-AA993B927515</gtr:id><gtr:impact>Presented update of research results to embryologists and research nurses from collaborating units

Continuing acquisition of research embryos from collaborating units</gtr:impact><gtr:outcomeId>3381F59A1A4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009,2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to Tissue bankers</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B8CEDADF-1720-425B-B172-276A28B1D558</gtr:id><gtr:impact>Glenda Cornwell Apr 07 - &amp;quot;Embryonic stem cell donation: The hESCCO experience&amp;quot; British Association for Tissue Banking

Information to general tissue banking audience about recruiting donors to embryonic stem cell reserach Published abstract Abstracts from the Annual Scientific Meeting of the British Association for tissue banking</gtr:impact><gtr:outcomeId>40E8505F8BA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brazilian Association for Stem Cell Therapy Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2FADB346-8ECB-4C2A-9F45-DB231B323FAD</gtr:id><gtr:impact>More than 200 people attended the talk

The presentation was followed with 15 minute Q+A session. Multiple questions form peers as well as from graduate students in audience</gtr:impact><gtr:outcomeId>he8g7QTEqQu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.abtcel2013.bio.br</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Clinical embryologist meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>B237346B-2901-433C-8671-F953F38DB5E2</gtr:id><gtr:impact>ACE meeting Edinburgh (Jan 09). &amp;quot;Implications of donating embryos for stem cell research&amp;quot;

None</gtr:impact><gtr:outcomeId>7E9FD7E6672</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Embryologist national meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>5BA4913E-8F69-411E-A40C-14A10EF38FE7</gtr:id><gtr:impact>Jan 09 - &amp;quot;Implications of donating embryos for stem cell research, ACE meeting, Edinburgh

Information for UK embryologists about stem cell research; need, and practical and ethical implications</gtr:impact><gtr:outcomeId>A727942E1A6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stem cells and regenerative medicine seminars, Ljubljana, Slovenia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7B58AA8A-31D2-4934-ACDE-D7235DCBE882</gtr:id><gtr:impact>About 30 undergraduate students and 10 faculties attanded a series of 6 lectures on stem cells and regeneratiev medicine

University of Ljubljana, Faculty of Pharmacy is currently applying for a Public Tender for cofinancing activities in years 2012-15, which stimulate openness of Slovenian Higher education into international environment released by Ministry of Education, Science, Culture and Sport - financed by the European Union and the Republic of Slovenia. 

D Ilic has been invited to participate as a guest expert and leader of international Workshop in Stem cells and Regenerative Mediince within the proposed project if being selected at the public tender.</gtr:impact><gtr:outcomeId>f2jQkohuZ2i</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Infertility nurses meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>85DB5050-486A-479B-A3E4-E697EB850DBB</gtr:id><gtr:impact>Glenda Cornwell Sept 07 - &amp;quot;Embryonic Stem Cell Research: The nurses role&amp;quot; National Fertility Nurse annual conference

Informing nurses involved in assisted conception units about need and use of surplus embryos for stem cell research</gtr:impact><gtr:outcomeId>25A3CD4B341</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>DKF Research Conference, Bern, Switzerland</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>98675133-7C26-417C-ADAA-A0DEDF0A5BED</gtr:id><gtr:impact>More than 100 academic researchers attanded the lecture

Intense Q&amp;amp;A session lasting more than 30 minutes</gtr:impact><gtr:outcomeId>SfjA7ApBDVV</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>video clip on BBC website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8A02DE51-50CA-47F7-B655-096B11CD597D</gtr:id><gtr:impact>SERIES: Health Explained
TITLE: How to make stem cells
DATE OF PUBLICATION: 21 Jun 2012
URL: www.bbc.co.uk/news/health-18496355

promoting our research</gtr:impact><gtr:outcomeId>DQRMiZqboNv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Refurbishment of IVF lab and stem cell laboratories</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>King's College London</gtr:fundingOrg><gtr:id>BC0719A3-0E15-42AD-A18A-14E52914B1F9</gtr:id><gtr:outcomeId>7599E6B11F30</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Welcome biomedical ethics strategic award</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>4C0A3BF1-6249-4240-845B-485B2C3F1FCE</gtr:id><gtr:outcomeId>1645EBBF2A90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>484420</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (G0801061)</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B6CB71D1-A7A9-4407-B791-3B5A169F104B</gtr:id><gtr:outcomeId>278CABF252D0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (G0701172)</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7DF71C45-1ABC-4F3D-981F-C7F63C8E7D3A</gtr:id><gtr:outcomeId>59B0706BC9F0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Route Map for Stem Cell Regulation</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>BE1FEB96-B56D-414C-9338-E9444C25A5BF</gtr:id><gtr:impact>Joint meeting of regulators to simplify processing of stem cell applications through HFEA, HTA, MHRA for clinical application</gtr:impact><gtr:outcomeId>71CD68B485D</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advisory Committee on Safety of Cells Tissues and Organs</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>EE2D62B8-1778-438B-9243-4D17D7A4137F</gtr:id><gtr:impact>Member advising on testing and use of reproductive and stem cell tissues.</gtr:impact><gtr:outcomeId>B2AC3159846</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Joint committee on the Human Tissue and Embryos (Draft) Bill</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>F88950C3-EB67-4D1D-9624-E45252D3E8BC</gtr:id><gtr:impact>Contributed to the demise of joint HFEA/HTA ALB to be called RATE. Remained as separate bodies and stem cell derivation remained under HFEA</gtr:impact><gtr:outcomeId>19D65C99E5D</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ESHRE PGD Guideline</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:guidelineTitle>ESHRE guidelines on practice of PGD</gtr:guidelineTitle><gtr:id>F59CDBF8-C7DA-4D63-99EF-33A853C62E54</gtr:id><gtr:impact>Revision of Guideline to influence standards and practice of preimplantation genetic diagnosis and preimplantation genetic screening which will form the basis of other documents and compliance with EU directives</gtr:impact><gtr:outcomeId>C8wCtckkuuu</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Progress Educational Trust Advisory Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ADCC8383-7A7E-4F6A-A160-58DA214375A3</gtr:id><gtr:outcomeId>TDzMumKveXM</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have so far derived 22 lines carrying clinically relevant genetic mutations derived from affected embryos following preimplantation genetic diagnosis (PGD) (HFEA licence R0075) which includes cystic fibrosis (4 lines), Huntington's disease (7 lines), myotonic dystrophy type 1 (1 line), neurofibromatosis type 1 (2 lines), spinal muscular atrophy type 1 (1 line), Von Hippel-Lindau cancer syndrome (3 lines), ?-thalassemia (2 line), Wiskott-Aldrich syndrome and cystic fibrosis carrer (1 line), and Turner syndrome (1 line).</gtr:description><gtr:id>29DB7687-39E4-414B-9ECF-132A3BEE901E</gtr:id><gtr:impact>The cells are or will be deposited in the UK Stem Cell Bank. The deposition process is ongoing. The cell lines will be then be available to other researchers. 
The cell lines are also sumnitted to NIH Registry</gtr:impact><gtr:outcomeId>652C4860224</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human embryonic stem cell lines with clinically relevant mutations</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://www.kcl.ac.uk/medicine/research/divisions/wh/groups/medicine/hescell.aspx</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have derived 9 lines from normal embryos cryopreserved in-house or from one of the ten collaborating IVF units (HFEA licence R0133).</gtr:description><gtr:id>ED2C37C8-C576-42C1-9335-4A17D7CC7B07</gtr:id><gtr:impact>The cell lines are either submitted or in process of submission to UKSCB. They will be available to researchers worldwide.</gtr:impact><gtr:outcomeId>059FB19D67D</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Reseearch grade normal hES cel lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The sixteen lines of stem cells on the NIH Registry carry genes for various hereditary disorders including Duchenne Muscular Dystrophy, Huntington's disease, cystic fibrosis, and rarer conditions such as Von Hippel-Lindau Syndrome, Wiskott-Aldrich syndrome, spinal muscular atrophy, myotonic dystrophy and neurofibromatosis.</gtr:description><gtr:id>5C0B1192-516C-45CE-B5CE-024C91FB7472</gtr:id><gtr:impact>Sixteen of human embryonic stem (hES) cell lines derived at King's have been approved by the US National Institutes of Health (NIH) and placed on their Stem Cell Registry, making them freely available for federally-funded research in the USA. 
King's is now one of the five biggest providers of disease-specific human embryonic stem cells lines on the NIH Registry, and the largest from the UK. The development is a significant milestone for King's and keeps the university at the forefront of global research into regenerative medicine.</gtr:impact><gtr:outcomeId>XQ6nWYQ7rom</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Human embryonic stem cell lines with clinically relevant mutations</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://grants.nih.gov/stem_cells/registry/current.htm</gtr:url></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>FB518DCC-CB87-497E-9BC6-AAB3CBCF98AA</gtr:id><gtr:title>Ethics of mitochondrial gene replacement: from bench to bedside.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da03624645d9044df6cdbb2072dcf62b"><gtr:id>da03624645d9044df6cdbb2072dcf62b</gtr:id><gtr:otherNames>Bredenoord AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>AQmAYmSRxzq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>515F7CC9-B177-4E57-89DD-A435BB88225C</gtr:id><gtr:title>Induced Pluripotent Stem Cell Differentiation and Three-Dimensional Tissue Formation Attenuate Clonal Epigenetic Differences in Trichohyalin.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d422635ae66ce33dfe3534035548820"><gtr:id>5d422635ae66ce33dfe3534035548820</gtr:id><gtr:otherNames>Petrova A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>585d67a3519ac0.35796925</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1E967AA-399F-46E4-BE66-81196E75696C</gtr:id><gtr:title>Generation of KCL036 research grade human embryonic stem cell line carrying a mutation in the HTT gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabf8a9295.33572115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A067C69-22C4-42C6-A6B0-B1606169E316</gtr:id><gtr:title>Human embryonic and induced pluripotent stem cells in clinical trials.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn><gtr:outcomeId>591c540d93c338.99534439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBF55B24-33BA-4AEC-BF40-F0BE6145785B</gtr:id><gtr:title>Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675e4d9ba809</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81B9ED36-E674-448E-9789-A222465229E0</gtr:id><gtr:title>Generation of KCL031 clinical grade human embryonic stem cell line.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfe7dd3ebf85.35028291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14EE65FF-9DDE-4AFC-9B5C-C0197F82163D</gtr:id><gtr:title>Generation of KCL037 clinical grade human embryonic stem cell line.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05dab0f87d4725838fc83d9f2ff612b9"><gtr:id>05dab0f87d4725838fc83d9f2ff612b9</gtr:id><gtr:otherNames>Miere C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfe7de0f3923.24841186</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>228A2277-E5D8-4EA0-9A0F-1B0F0EC4BE56</gtr:id><gtr:title>Global update: England and Wales.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>pm_13460_20_21999278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>859E58F7-F5A0-4509-B5C4-EF2A0902713E</gtr:id><gtr:title>Cost-effective master cell bank validation of multiple clinical-grade human pluripotent stem cell lines from a single donor.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b307bcfeb7e0c589beee950062707ff7"><gtr:id>b307bcfeb7e0c589beee950062707ff7</gtr:id><gtr:otherNames>Devito L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn><gtr:outcomeId>545cb0839bc769.10816229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FC5D8A4-C5C4-4461-B1E8-B1EAD2330D18</gtr:id><gtr:title>'Not taken in by media hype': how potential donors, recipients and members of the general public perceive stem cell research.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7d60bb449f1fb09cba275e964ad4297"><gtr:id>e7d60bb449f1fb09cba275e964ad4297</gtr:id><gtr:otherNames>Peddie VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>390F54837AD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DBA9731-812D-45A7-B83D-2E24027B1CEC</gtr:id><gtr:title>Generation of KCL021 research grade human embryonic stem cell line carrying a ?F508 mutation in the CFTR gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05dab0f87d4725838fc83d9f2ff612b9"><gtr:id>05dab0f87d4725838fc83d9f2ff612b9</gtr:id><gtr:otherNames>Miere C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabdcf59c3.74348160</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B31A28E4-B1DA-4ED7-8CDC-5B39B268A706</gtr:id><gtr:title>Derivation of the King's College London human embryonic stem cell lines.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71cee36ebeeaa4bc610dcbf2411b4d7b"><gtr:id>71cee36ebeeaa4bc610dcbf2411b4d7b</gtr:id><gtr:otherNames>Stephenson EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn><gtr:outcomeId>F8BPbFbDzcQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D93C059F-8582-4009-9395-4E1467803CB4</gtr:id><gtr:title>Generation of KCL029 research grade human embryonic stem cell line carrying a mutation in WAS gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05dab0f87d4725838fc83d9f2ff612b9"><gtr:id>05dab0f87d4725838fc83d9f2ff612b9</gtr:id><gtr:otherNames>Miere C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabdedb331.39639850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96051306-030B-4234-9EAB-2146640B2990</gtr:id><gtr:title>Concise Review: Human Embryonic Stem Cells-What Have We Done? What Are We Doing? Where Are We Going?</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>591c5310c996a4.42259481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>948EAFB2-C8ED-403F-80ED-AD79B4E66A5E</gtr:id><gtr:title>Industry highlights: Stem cell and regenerative medicine.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>pm_13460_20_21999262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A921E4F-70F2-4AAA-9428-9952AE5E1154</gtr:id><gtr:title>Generation of KCL013 research grade human embryonic stem cell line carrying a mutation in the HTT gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabeb95109.13794114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2295363E-76DE-48E9-8256-69BB48CCBE4C</gtr:id><gtr:title>Generation of KCL038 clinical grade human embryonic stem cell line.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05dab0f87d4725838fc83d9f2ff612b9"><gtr:id>05dab0f87d4725838fc83d9f2ff612b9</gtr:id><gtr:otherNames>Miere C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfe7de2f8393.43621063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>832EC12C-077D-456D-98E6-D0DD55AD58E9</gtr:id><gtr:title>Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec60da3dddaae680a3c7dee1eecb5322"><gtr:id>ec60da3dddaae680a3c7dee1eecb5322</gtr:id><gtr:otherNames>Merkle FT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>591c53a89a51d4.32929236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DA95C61-461A-4813-ABC8-01AC31DB1129</gtr:id><gtr:title>Generation of KCL035 research grade human embryonic stem cell line carrying a mutation in HBB gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5906459f71b6363885611cb5abc8de3a"><gtr:id>5906459f71b6363885611cb5abc8de3a</gtr:id><gtr:otherNames>Hewitson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabf467b30.23978198</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57335771-299A-456F-8DFF-D5D8C719B877</gtr:id><gtr:title>A thyroid hormone receptor/KLF9 axis in human hepatocytes and pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a797eafd1bb17c15af4402c6907e1de9"><gtr:id>a797eafd1bb17c15af4402c6907e1de9</gtr:id><gtr:otherNames>Cvoro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>545cb08375bf84.92119309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B01C1E2F-65CD-4E82-A760-3D20900E51DF</gtr:id><gtr:title>Clinically failed eggs as a source of normal human embryo stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba0b6035e4458fc14d9c61658be76e45"><gtr:id>ba0b6035e4458fc14d9c61658be76e45</gtr:id><gtr:otherNames>De Sousa PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>48BC2B57FF8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8218B08D-E4DF-4E18-9C28-368736CDF918</gtr:id><gtr:title>Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions.</gtr:title><gtr:parentPublicationTitle>Cytotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1465-3249</gtr:issn><gtr:outcomeId>DxJAviPZfEf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0BE1544-7681-47FD-9F30-67492A3E750D</gtr:id><gtr:title>Generation of KCL017 research grade human embryonic stem cell line carrying a mutation in VHL gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5906459f71b6363885611cb5abc8de3a"><gtr:id>5906459f71b6363885611cb5abc8de3a</gtr:id><gtr:otherNames>Hewitson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabf26f7f2.43579406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DE447FB-E8AD-4164-9352-61CB2C15BBB8</gtr:id><gtr:title>Generation of KCL027 research grade human embryonic stem cell line carrying a mutation in the HTT gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabe573a71.46578135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FCEEBD5-DE98-4D25-9C04-ECDE4201676A</gtr:id><gtr:title>ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da37d2f1b965b445443b18dc09b1f837"><gtr:id>da37d2f1b965b445443b18dc09b1f837</gtr:id><gtr:otherNames>Harton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>KFBMbLEbZ2R</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1A42407-BB16-433D-8C19-0CE8C4E3E204</gtr:id><gtr:title>Trends in the stem cell and regenerative medicine industry.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>pm_13460_20_22954435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>010BFEDF-F36F-40E1-A3F1-AD26F8B1D3E3</gtr:id><gtr:title>The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93977d2ba9fe935c99b3418690c14eaf"><gtr:id>93977d2ba9fe935c99b3418690c14eaf</gtr:id><gtr:otherNames>Canham MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56dfe7dd84ba78.22490193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A4CB847-5035-4C77-A72A-442F766F8E2B</gtr:id><gtr:title>Generation of KCL033 clinical grade human embryonic stem cell line.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b307bcfeb7e0c589beee950062707ff7"><gtr:id>b307bcfeb7e0c589beee950062707ff7</gtr:id><gtr:otherNames>Devito L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfe7ddab98d0.05138924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46114153-8F7B-41F6-BC7D-6265B2E4E716</gtr:id><gtr:title>Preimplantation genetic diagnosis as a source of human embryonic stem cells for disease research and drug discovery.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71cee36ebeeaa4bc610dcbf2411b4d7b"><gtr:id>71cee36ebeeaa4bc610dcbf2411b4d7b</gtr:id><gtr:otherNames>Stephenson EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>0C251DDFDEE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6FE1116-E59A-4C5C-8F42-A5832E69C56C</gtr:id><gtr:title>Generation of KCL012 research grade human embryonic stem cell line carrying a mutation in the HTT gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabf029060.78591876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>547A3671-4D72-4783-BBF5-CE5CDB01D491</gtr:id><gtr:title>Generation of KCL040 clinical grade human embryonic stem cell line.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfe7de9459a0.07443842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC8C9B35-121E-48B0-A3A4-66F09D807A3C</gtr:id><gtr:title>Generation of KCL016 research grade human embryonic stem cell line carrying a mutation in VHL gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05dab0f87d4725838fc83d9f2ff612b9"><gtr:id>05dab0f87d4725838fc83d9f2ff612b9</gtr:id><gtr:otherNames>Miere C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabdafe206.09959069</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>756DC89F-9522-4923-A799-262D8F797294</gtr:id><gtr:title>Generation of KCL018 research grade human embryonic stem cell line carrying a mutation in the DMPK gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05dab0f87d4725838fc83d9f2ff612b9"><gtr:id>05dab0f87d4725838fc83d9f2ff612b9</gtr:id><gtr:otherNames>Miere C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabf69cca5.52619446</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35321F09-947A-487F-9550-A80DA4A820E4</gtr:id><gtr:title>Stem cell based therapy--where are we going?</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_13460_20_22405784</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD1C5CCD-3D84-430E-876E-B34CAA54A3E1</gtr:id><gtr:title>Generation of KCL025 research grade human embryonic stem cell line carrying a mutation in NF1 gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5906459f71b6363885611cb5abc8de3a"><gtr:id>5906459f71b6363885611cb5abc8de3a</gtr:id><gtr:otherNames>Hewitson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabe791cd9.91030009</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14AFF706-7A8C-411C-8C68-9DF2303E5D93</gtr:id><gtr:title>Generation of KCL028 research grade human embryonic stem cell line carrying a mutation in the HTT gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabe1b3f12.66910909</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A10FC05-D73E-449B-AC63-2F19B0F81B98</gtr:id><gtr:title>The procurement of cells for the derivation of human embryonic stem cell lines for therapeutic use: recommendations for good practice.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ae23803e6e96e9fac7081387c099d5"><gtr:id>f0ae23803e6e96e9fac7081387c099d5</gtr:id><gtr:otherNames>Murdoch A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>RWMp83waEcv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4320A1D1-3EE0-4C56-8458-66B92F7DEECE</gtr:id><gtr:title>Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e2c772848d7675ee6ce668c80fc6d9c"><gtr:id>3e2c772848d7675ee6ce668c80fc6d9c</gtr:id><gtr:otherNames>Stephenson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>dQswUNUA8VG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1974342F-BF17-4545-99BC-6BAB87A7AFAA</gtr:id><gtr:title>Generation of KCL034 clinical grade human embryonic stem cell line.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b307bcfeb7e0c589beee950062707ff7"><gtr:id>b307bcfeb7e0c589beee950062707ff7</gtr:id><gtr:otherNames>Devito L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfe7dddedc44.11433763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10DA1625-2C0A-41AB-AEF1-629CF81B9454</gtr:id><gtr:title>Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e2c772848d7675ee6ce668c80fc6d9c"><gtr:id>3e2c772848d7675ee6ce668c80fc6d9c</gtr:id><gtr:otherNames>Stephenson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>pm_13460_20_22722371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8642594A-2190-4E52-81A1-44DC0A82326B</gtr:id><gtr:title>Stem cells in regenerative medicine: introduction.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fab8c9425f975720e58fc9438c517385"><gtr:id>fab8c9425f975720e58fc9438c517385</gtr:id><gtr:otherNames>Ilic D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn><gtr:outcomeId>pm_13460_20_21565803</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73BEE546-D6EE-4FBC-8EE0-8B7E1C906EFA</gtr:id><gtr:title>3D In vitro model of a functional epidermal permeability barrier from human embryonic stem cells and induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d422635ae66ce33dfe3534035548820"><gtr:id>5d422635ae66ce33dfe3534035548820</gtr:id><gtr:otherNames>Petrova A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>545cb083ef8414.27126137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B937C776-1667-4AF7-AEED-9A6480D9DED0</gtr:id><gtr:title>Generation of KCL032 clinical grade human embryonic stem cell line.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05dab0f87d4725838fc83d9f2ff612b9"><gtr:id>05dab0f87d4725838fc83d9f2ff612b9</gtr:id><gtr:otherNames>Miere C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfe7dd64d6a0.90847823</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AD92184-CFA4-4CA6-B310-A355E11380D2</gtr:id><gtr:title>Generation of KCL039 clinical grade human embryonic stem cell line.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b307bcfeb7e0c589beee950062707ff7"><gtr:id>b307bcfeb7e0c589beee950062707ff7</gtr:id><gtr:otherNames>Devito L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfe7de6ac3a9.81367153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7948B2F1-1961-4845-826E-2CBD42436E93</gtr:id><gtr:title>Generation of KCL026 research grade human embryonic stem cell line carrying a mutation in SMN1 gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5906459f71b6363885611cb5abc8de3a"><gtr:id>5906459f71b6363885611cb5abc8de3a</gtr:id><gtr:otherNames>Hewitson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabe990b17.49728038</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E2685B6-3672-49C4-8EB5-409ACF19C0DF</gtr:id><gtr:title>Generation of KCL024 research grade human embryonic stem cell line carrying a mutation in NF1 gene.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5906459f71b6363885611cb5abc8de3a"><gtr:id>5906459f71b6363885611cb5abc8de3a</gtr:id><gtr:otherNames>Hewitson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56dfeabed5fa74.67055262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE728693-05A5-4B56-BA3B-D87DE1CBD897</gtr:id><gtr:title>Strategy for the creation of clinical grade hESC line banks that HLA-match a target population.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a2afc7287a20b64627a082796f08d86"><gtr:id>4a2afc7287a20b64627a082796f08d86</gtr:id><gtr:otherNames>Jacquet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>pm_13460_20_23161805</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801061</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>